For 44 years, this investor held aces in the long-bond game. He just folded.
Lacy Hunt’s about-face on long-term Treasurys marks the end of an era. Here’s what it means for your money.
Lacy Hunt’s about-face on long-term Treasurys marks the end of an era. Here’s what it means for your money.
Two decades ago, the architect Jeremy Kotas, a Frank Gehry protege, was given something few architects get: a clean slate in the form of a 20-acre parcel in Marin. The resulting home, at 200 Mountain King Road in Lagunitas, California, is now being sold for $4.4 million. “Properties with this combination of attributes rarely come…
The Samsung Electronics Co. signage at the company’s Seocho office building in Seoul, South Korea, on Monday, June 29, 2026. SeongJoon Cho | Bloomberg | Getty Images Samsung Electronics and its affiliates will invest a combined $1 billion in Helix Digital Infrastructure, an artificial intelligence infrastructure company launched by global investment firm KKR and backed…
The stock market has been on an impressive run since the 2022 bear market. The S&P 500 (^GSPC -0.22%) — which tracks the largest 500 American companies on the stock market — has strung together three consecutive years of double-digit returns and is up 13% as of market close on Aug. 7. There are no…
Global Banking & Finance Review® is an online platform providing news, analysis, interviews, opinions, press releases, market information and other content relating to banking, finance, insurance, investment, wealth management, fintech, financial markets, technology, regulation and related industries worldwide. The website publishes editorial content, news, press releases, contributed articles, sponsored content, advertorials, advertisements and other material…
Adding to the pressure President Donald Trump has placed on the Federal Reserve to cut borrowing costs, Vice President JD Vance said that the Central Bank should cut interest rates to make homes more affordable, Vance’s remarks came days after Trump’s handpicked Fed Chair, Kevin Warsh, hinted at the possibility of doing the opposite: hiking…
SHANGHAI, Aug. 4, 2026 /PRNewswire/ — Innogen Pharmaceuticals (HK.2591), a biopharmaceutical company dedicated to innovative drug discovery and industrialization in metabolic diseases, today announced that its Efsubaglutide alfa manufacturing facility in Suzhou has officially passed a compliance inspection conducted by the Brazilian National Health Surveillance Agency (ANVISA) in accordance with the Pharmaceutical Inspection Co-operation Scheme…